Bank of Montreal’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-27,100
| Closed | -$11K | – | 5099 |
|
|
2018
Q4 | $11K | Sell |
27,100
-38,000
| -58% | -$23.6K | ﹤0.01% | 3871 |
|
|
2018
Q3 | $63K | Buy |
65,100
+2,100
| +3% | +$3.51K | ﹤0.01% | 3292 |
|
|
2018
Q2 | $153K | Buy |
63,000
+60,000
| +2,000% | +$147K | ﹤0.01% | 2900 |
|
|
2018
Q1 | $7K | Buy |
+3,000
| New | +$7.57K | ﹤0.01% | 3873 |
|
|
2016
Q3 | – | Sell |
-5
| Closed | – | – | 4325 |
|
|
2016
Q2 | $0 | Sell |
5
-413
| -99% | -$2.7K | ﹤0.01% | 4528 |
|
|
2016
Q1 | $4K | Sell |
418
-104,110
| -100% | -$2.07M | ﹤0.01% | 3878 |
|
|
2015
Q4 | $3.08M | Buy |
104,528
+23,683
| +29% | +$716K | ﹤0.01% | 1197 |
|
|
2015
Q3 | $2.56M | Sell |
80,845
-1,101
| -1% | -$52.7K | ﹤0.01% | 1200 |
|
|
2015
Q2 | $4.85M | Buy |
81,946
+197
| +0.2% | +$13.9K | 0.01% | 1068 |
|
|
2015
Q1 | $8.74M | Sell |
81,749
-4,685
| -5% | -$447K | 0.01% | 858 |
|
|
2014
Q4 | $8.12M | Sell |
86,434
-47,613
| -36% | -$4.54M | 0.01% | 861 |
|
|
2014
Q3 | $10.3M | Buy |
134,047
+5,471
| +4% | +$431K | 0.01% | 791 |
|
|
2014
Q2 | $11.5M | Buy |
+128,576
| New | +$7.88M | 0.01% | 755 |
|
Bank of Montreal's PTX Position: Q1 2019 in Review
Bank of Montreal sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 27,100 shares — an estimated $11K sold.
Bank of Montreal first reported a position in PTX in Q2 2014 and held it in 13 quarters. The position peaked at $11.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Bank of Montreal reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Bank of Montreal sold 27,100 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $11K.
- Bank of Montreal first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 13 quarters.
- Bank of Montreal's Pernix Therapeutics Holdings, Inc. position peaked at $11.5M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.